NRIX insider plans sale of 4,761 shares

NRIX security holder Johannes Van Houte has filed to sell common stock under Rule 144.

Rhea-AI Filing Summary

NRIX security holder Johannes Van Houte has filed to sell common stock under Rule 144. The filing lists 4,761 common shares to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate value of $110,550.42. These shares are tied to Restricted Stock Units dated July 30, 2026.

The filing also reports prior sales in the last three months: 2,845 common shares sold on July 30, 2026 for $66,524.07, and 14,055 common shares sold on May 5, 2026 for $233,319.27, identified as 10b5-1 sales for Johannes Van Houte.

Key Figures

Planned shares to be sold: 4,761 shares Planned sale value: $110,550.42 Security identifier: 103781683 +3 more

6 metrics

Planned shares to be sold 4,761 shares Common stock to be sold through Morgan Stanley Smith Barney LLC on NASDAQ

Planned sale value $110,550.42 Aggregate value for 4,761 common shares listed in the Form 144

Security identifier 103781683 Identifier associated with the NRIX common stock in the filing

Recent sale on July 30, 2026 2,845 shares for $66,524.07 Common stock sale by Johannes Van Houte during past three months

Recent sale on May 5, 2026 14,055 shares for $233,319.27 Common stock 10b5-1 sale by Johannes Van Houte

RSU date 07/30/2026 Restricted Stock Units associated with the common shares

Key Terms

Restricted Stock Units, 10b5-1 Sales, Form 144

3 terms

Restricted Stock Units financial

"Common | 07/30/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 Sales financial

"10b5-1 Sales for JOHANNES VAN HOUTE 1600 Sierra"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is disclosed for NRIX in this Form 144?

The filing discloses a planned sale of 4,761 common shares of NRIX through Morgan Stanley Smith Barney LLC, with an aggregate value of $110,550.42, to be sold on NASDAQ.

Who is the selling security holder in the NRIX Form 144?

The selling security holder is Johannes Van Houte, with an address at 1600 Sierra Point Parkway, Brisbane, CA 94005, reporting planned and recent sales of NRIX common stock.

What recent NRIX stock sales have occurred before this Form 144?

The filing lists sales of 2,845 shares on July 30, 2026 for $66,524.07 and 14,055 shares on May 5, 2026 for $233,319.27, both involving NRIX common stock.

Are the NRIX stock sales under a 10b5-1 plan?

Yes. The Form 144 notes 10b5-1 Sales for Johannes Van Houte, including 14,055 NRIX common shares sold on May 5, 2026 for $233,319.27 pursuant to such a plan.

What type of NRIX security is involved in the Form 144 filing?

The filing covers NRIX common stock, with the planned sale of 4,761 common shares and prior sales tied to Restricted Stock Units dated July 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/04/2026 - 04:35 PM Accepted by SEC EDGAR 08/04/2026 - 04:33 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001817217
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NURIX THERAPEUTICS INC
SEC File Number	001-39398
Address of Issuer	1600 Sierra Point Parkway Brisbane CALIFORNIA 94005
Phone	4156605320
Name of Person for Whose Account the Securities are To Be Sold	JOHANNES VAN HOUTE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4761	110550.42	103781683	08/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/30/2026	Restricted Stock Units	Issuer			4761	07/30/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JOHANNES VAN HOUTE 1600 Sierra Point Parkway Brisbane CA 94005	Common	07/30/2026	2845	66524.07
10b5-1 Sales for JOHANNES VAN HOUTE 1600 Sierra Point Parkway Brisbane CA 94005	Common	05/05/2026	14055	233319.27

144: Remarks and Signature

Remarks
Date of Notice	08/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Johannes van Houte
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)